|
Xie Dong--Independent non-executive Director |
|
|
|
 Xie Dong--Independent non-executive Director
Mr. Xie Dong, born in 1980, obtained his bachelor’s degree in Economics in 2003 and master’s degree in World Economics from Nankai University in 2006, respectively. He has over 19 years of professional experience in sectors of finance, auditing, investment and financing, and capital markets, and is the holder of Chinese Institute of Certified Public Accountants (CICPA), Certified Internal Auditor (CIA), Certified Tax Agent (CTA) and Chinese Legal Professional Qualification. From June 2006 to October 2007, he worked as the auditor of the global financial services department of Ernst & Young Hua Ming LLP; from November 2007 to March 2010 and from October 2010 to August 2014, he served as the deputy director of M&A (Mergers and Acquisitions) Financial Advisory Services Department of Deloitte; from April 2010 to September 2010, he was appointed as Vice President of direct investment department of CCB International (China) Limited; from September 2014 to December 2018, he served as the chief financial officer and company secretary of FinUp Finance Technology Group (Holding) Limited; from January 2019 to March 2020, he served as the chief financial officer of Renbuy Technology Holding (任買科技控股); from March 2020 to December 2020, the partner (capital market services) of PGA Consulting Limited. He served as the chief financial officer, director and senior vice president of Here Group Limited (NASDAQ: HERE) (formerly QuantaSing Group Limited, NASDAQ: QSG) since January 2021, June 2022 and October 2025. In May 2021, he was appointed as the independent non-executive director of the Company. In April 2025, he was appointed as the independent non-executive director of Duality Biotherapeutics, Inc. (09606. HK). In October 2025, he was appointed as the independent non-executive director of Dazhong Dental (02651.HK). |
|
|
|
